What is Achieve Life Sciences's free cash flow yield?

Achieve Life Sciences (ACHV) reported free cash flow yield of -18.7% in Q4 2025.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

Achieve Life Sciences ACHV Free cash flow yield

Free cash flow yield at other companies

PfizerPFE

7.8%+4.6pp

Sionna Therapeutics, Inc. Common StockSION

-4%—

Philip Morris InternationalPM

4.1%0.0pp

Other financials

Income statement

See full

Net income-$10.2M+20.7%

EPS (diluted)-$0.19+48.6%

Balance sheet

See full

Cash & equivalents$28.1M+116%

Total debt$5.6M+332%

Total equity$10.7M+3.9%

Total assets$33.1M+21.0%

Cash flow

See full

Operating cash flow-$6.9M+37.5%

CapEx$750.0—

Free cash flow-$12.4M—

Valuation

See full

Market cap$585.16M+404%

Enterprise value$562.71M+439%

Returns & leverage

See full

Return on equity-496.1%-906pp

Debt / equity0.5×+0.4×

Current ratio2.6×-0.9×

Where this comes from

Calculated from Achieve Life Sciences’s reported figures.

free cash flow/market cap=-18.7%

Based on trailing twelve months.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Achieve Life Sciences's free cash flow yield?: Achieve Life Sciences (ACHV) reported free cash flow yield of -18.7% in Q4 2025.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.